HEALTHPEAK PROPERTIES INC (DOC) Forecast, Price Target & Analyst Ratings
NYSE:DOC • US42250P1030
17.42 USD
+0.14 (+0.81%)
At close: Mar 9, 2026
17.39 USD
-0.03 (-0.17%)
After Hours: 3/9/2026, 8:04:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for HEALTHPEAK PROPERTIES INC (DOC).
Forecast Snapshot
Consensus Price Target
$19.83
+ 13.81% Upside
Next Earnings Forecast
Release DateApr 22, 2026
PeriodQ1 / 2026
EPS Estimate$0.06
Revenue Estimate699.5M
ChartMill Buy Consensus
73.91%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$19.83
Upside
+ 13.81%
From current price of $17.42 to mean target of $19.83, Based on 23 analyst forecasts
Low
$16.16
Median
$19.38
High
$30.45
Price Target Revisions
1 Month
-2.20%
3 Months
-5.32%
Price Target Summary
23 Wall Street analysts provided a forecast for the next 12 months for DOC. The average price target is 19.83 USD. This implies a price increase of 13.81% is expected in the next year compared to the current price of 17.42.
The average price target has been revised downward by 5.32% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
73.91%
DOC was analyzed by 23 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about DOC.
In the previous month the buy percentage consensus was at a similar level.
DOC was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-05 | Argus Research | Downgrade | Buy -> Hold |
| 2026-02-04 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2026-02-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2026-01-09 | Goldman Sachs | Initiate | Neutral |
| 2025-12-16 | Jefferies | Downgrade | Buy -> Hold |
| 2025-12-15 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-11-25 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-11-12 | Baird | Maintains | Outperform -> Outperform |
| 2025-10-01 | Cantor Fitzgerald | Initiate | Neutral |
| 2025-09-15 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2025-08-27 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-22 | Morgan Stanley | Maintains | Overweight -> Overweight |
| 2025-08-20 | Deutsche Bank | Downgrade | Buy -> Hold |
| 2025-07-30 | Baird | Maintains | Outperform -> Outperform |
| 2025-07-29 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
| 2025-06-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-12 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-04-29 | Argus Research | Reiterate | Buy -> Buy |
| 2025-04-29 | Baird | Maintains | Outperform -> Outperform |
| 2025-04-28 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-04-28 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-04-11 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-02-28 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-14 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-02-11 | Baird | Maintains | Outperform -> Outperform |
Next Earnings Forecast Details
Next Earnings Details
Release DateApr 22, 2026
PeriodQ1 / 2026
EPS Estimate$0.06
Revenue Estimate699.5M
Revenue Q2Q-0.48%
EPS Q2Q1.00%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
-0.07%
Revenue (3 Months)
-1.17%
EPS (1 Month)
-4.00%
EPS (3 Months)
-3.23%
Next Earnings Summary
DOC is expected to report earnings on 4/22/2026. The consensus EPS estimate for the next earnings is 0.06 USD and the consensus revenue estimate is 699.50M USD.
The next earnings revenue estimate has been revised downward by 1.17% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.181B 5.81% | 2.7B 23.82% | 2.823B 4.52% | 2.823B 0.02% | 2.935B 3.97% | 3.124B 6.44% | 3.467B 10.98% | 3.66B 5.57% | 3.847B 5.11% | 4.03B 4.76% | 4.216B 4.62% | |
| EBITDA YoY % growth | 1.189B 7.66% | 1.519B 27.67% | 1.604B 5.62% | 1.582B -1.36% | 1.647B 4.11% | 1.793B 8.86% | 1.959B 9.26% | 2.066B 5.46% | 2.17B 5.03% | 2.272B 4.70% | 2.376B 4.58% | |
| EBIT YoY % growth | 439.511M 11.49% | 461.361M 4.97% | 545.025M 18.13% | 488.08M -10.45% | 521.34M 6.81% | 572.18M 9.75% | 637.47M 11.41% | 687.68M 7.88% | 731.41M 6.36% | 771.44M 5.47% | 814.93M 5.64% | |
| Operating Margin | 20.15% | 17.08% | 19.31% | 17.29% | 17.76% | 18.32% | 18.39% | 18.79% | 19.01% | 19.14% | 19.33% | |
| EPS YoY % growth | 0.56 -38.86% | 0.35 -37.50% | 0.35 | 0.22 -37.96% | 0.25 13.18% | 0.26 4.80% | 0.30 17.65% | 0.36 20.00% | 0.41 13.89% | 0.46 12.20% | 0.52 10.87% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.06 1.00% | 0.06 14.47% | 0.06 -20.05% | 0.07 -57.39% | 0.07 8.33% | 0.07 23.52% | 0.07 10.53% | 0.07 3.70% |
| Revenue Q2Q % growth | 699.5M -0.48% | 703.18M 1.27% | 708.93M 0.43% | 726.12M 0.93% | 735.95M 5.21% | 744.07M 5.82% | 752.32M 6.12% | 764.07M 5.23% |
| EBITDA Q2Q % growth | 390.38M -4.13% | 394.31M -40.48% | 407.81M -56.08% | 421.45M -65.04% | 422.91M 8.33% | 431.17M 9.35% | 435.92M 6.89% | 440.87M 4.61% |
| EBIT Q2Q % growth | 134.26M -3.16% | 133.93M 4.64% | 163.83M 24.32% | 148.27M 1.13% | 156.25M 16.38% | 161.1M 20.29% | 164.53M 0.43% | N/A |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-9.72%
EPS Next 5 Year
0.77%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
3.92%
Revenue Next 5 Year
5.62%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
58.98%
EBIT Next 5 Year
35.87%
HEALTHPEAK PROPERTIES INC / DOC Forecast FAQ
Can you provide the average price target for HEALTHPEAK PROPERTIES INC stock?
23 analysts have analysed DOC and the average price target is 19.83 USD. This implies a price increase of 13.81% is expected in the next year compared to the current price of 17.42.
What is the next earnings date for DOC stock?
HEALTHPEAK PROPERTIES INC (DOC) will report earnings on 2026-04-22.
Can you provide the consensus estimates for HEALTHPEAK PROPERTIES INC next earnings?
The consensus EPS estimate for the next earnings of HEALTHPEAK PROPERTIES INC (DOC) is 0.06 USD and the consensus revenue estimate is 699.50M USD.
How many analysts have analysed HEALTHPEAK PROPERTIES INC (DOC)?
The number of analysts covering HEALTHPEAK PROPERTIES INC (DOC) is 23.